Inventor · disambiguated record
Liang Shan
Also filed as: SHAN LIANG
5 granted patents·5 pending applications·9 citations·filing 2015–2025
73Inventor score
Top patents by PatentIndex Score
10 records- 0187US10561126B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Feb 18, 2020·5 cites·22 claims
- 0283US10123518B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·3 cites·28 claims
- 0377US2023292721A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0474US10463028B2Genetically modified non-human animals expressing human EPOREGENERON PHARMA·Filed 2015·Granted Nov 5, 2019·1 cites·19 claims
- 0564US2024074414A1Genetically modified non-human animals expressing human epoREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0662US11576356B2Genetically modified non-human animals and methods of use thereofREGENEREN PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 0759US11766032B2Genetically modified non-human animals expressing human EPOREGENERON PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 0852US2025325708A1Crispr-dcas9-mediated induction of cd16/fcgr3a gene expression in human natural killer cellsUNIV TEMPLE·Filed 2025·Application pending·0 cites
- 0937US2017360920A1Method and compositions for the prevention and treatment of a hiv infectionUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 1037US2017274001A1Compositions and Methods for Increasing Red Blood CellsUNIV YALE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liang Shan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →